The ubiquitin-like modifier FAT10 is not essential for MHC-I antigen presentation
| dc.contributor.author | Pach, Natalie | |
| dc.contributor.author | Ochs, Sarah | |
| dc.contributor.author | Cao, Jinjing | |
| dc.contributor.author | Ottlinger, Julia | |
| dc.contributor.author | Aichem, Annette | |
| dc.contributor.author | Basler, Michael | |
| dc.date.accessioned | 2025-09-05T10:32:04Z | |
| dc.date.available | 2025-09-05T10:32:04Z | |
| dc.date.issued | 2025 | |
| dc.description.abstract | Introduction: The presentation of pathogen-derived antigens on major histocompatibility complex (MHC) class I is crucial for the antiviral immune response. Degradation of intracellular pathogen-derived proteins by the 26S proteasome generates peptides that can be loaded on MHC-I molecules and presented to cytotoxic T cells. The cytokine-inducible ubiquitin-like modifier (ULM) HLA-F adjacent transcript 10 (FAT10) is encoded in the MHC locus and targets its substrates for proteasomal degradation. Therefore, it acts as an alternative signal for protein degradation, indicating a role in generating the peptide pool for MHC-I presentation. In this study, we aimed to elucidate the role of FAT10 in MHC class I presentation. Methods: Using different human and mouse cell lines deficient for FAT10, the effect of FAT10 on MHC-I surface expression and recovery was studied. For the evaluation of antigen presentation of viral and endogenous epitopes, T cell hybridoma assays and flow cytometry analysis were used. Results: In our study, using model antigens and FAT10-deficient cells, we found that the absence of FAT10 does not affect the abundance of MHC-I molecules or the generation of endogenous and virus-derived MHC-I epitopes. Furthermore, we demonstrated that the cytotoxic T cell response to different viruses remains unchanged in FAT10-deficient mice compared to wild-type mice. Discussion: In summary, our findings indicate that the lack of FAT10 does not impact antigen presentation or the cytotoxic T-cell response across a number of different MHC-I-restricted peptides. Hence, we conclude that the contribution of FAT10 to MHC-I antigen presentation has previously been overestimated. | |
| dc.description.version | published | deu |
| dc.identifier.doi | 10.3389/fimmu.2025.1636951 | |
| dc.identifier.ppn | 1935351699 | |
| dc.identifier.uri | https://kops.uni-konstanz.de/handle/123456789/74477 | |
| dc.language.iso | eng | |
| dc.rights | terms-of-use | |
| dc.rights.uri | https://rightsstatements.org/page/InC/1.0/ | |
| dc.subject | FAT10 | |
| dc.subject | UBD | |
| dc.subject | Proteasome | |
| dc.subject | MHC-I | |
| dc.subject | antigen processing | |
| dc.subject | Antigen Presentation | |
| dc.subject | Cytotoxic T Cells | |
| dc.subject.ddc | 570 | |
| dc.title | The ubiquitin-like modifier FAT10 is not essential for MHC-I antigen presentation | eng |
| dc.type | JOURNAL_ARTICLE | |
| dspace.entity.type | Publication | |
| kops.citation.bibtex | @article{Pach2025ubiqu-74477,
title={The ubiquitin-like modifier FAT10 is not essential for MHC-I antigen presentation},
year={2025},
doi={10.3389/fimmu.2025.1636951},
volume={16},
journal={Frontiers in Immunology},
author={Pach, Natalie and Ochs, Sarah and Cao, Jinjing and Ottlinger, Julia and Aichem, Annette and Basler, Michael},
note={Article Number: 1636951}
} | |
| kops.citation.iso690 | PACH, Natalie, Sarah OCHS, Jinjing CAO, Julia OTTLINGER, Annette AICHEM, Michael BASLER, 2025. The ubiquitin-like modifier FAT10 is not essential for MHC-I antigen presentation. In: Frontiers in Immunology. Frontiers. 2025, 16, 1636951. eISSN 1664-3224. Verfügbar unter: doi: 10.3389/fimmu.2025.1636951 | deu |
| kops.citation.iso690 | PACH, Natalie, Sarah OCHS, Jinjing CAO, Julia OTTLINGER, Annette AICHEM, Michael BASLER, 2025. The ubiquitin-like modifier FAT10 is not essential for MHC-I antigen presentation. In: Frontiers in Immunology. Frontiers. 2025, 16, 1636951. eISSN 1664-3224. Available under: doi: 10.3389/fimmu.2025.1636951 | eng |
| kops.citation.rdf | <rdf:RDF
xmlns:dcterms="http://purl.org/dc/terms/"
xmlns:dc="http://purl.org/dc/elements/1.1/"
xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
xmlns:bibo="http://purl.org/ontology/bibo/"
xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
xmlns:foaf="http://xmlns.com/foaf/0.1/"
xmlns:void="http://rdfs.org/ns/void#"
xmlns:xsd="http://www.w3.org/2001/XMLSchema#" >
<rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/74477">
<dc:contributor>Ottlinger, Julia</dc:contributor>
<foaf:homepage rdf:resource="http://localhost:8080/"/>
<dc:creator>Cao, Jinjing</dc:creator>
<dc:rights>terms-of-use</dc:rights>
<dc:contributor>Ochs, Sarah</dc:contributor>
<dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2025-09-05T10:32:04Z</dcterms:available>
<dc:language>eng</dc:language>
<dcterms:abstract>Introduction: The presentation of pathogen-derived antigens on major histocompatibility complex (MHC) class I is crucial for the antiviral immune response. Degradation of intracellular pathogen-derived proteins by the 26S proteasome generates peptides that can be loaded on MHC-I molecules and presented to cytotoxic T cells. The cytokine-inducible ubiquitin-like modifier (ULM) HLA-F adjacent transcript 10 (FAT10) is encoded in the MHC locus and targets its substrates for proteasomal degradation. Therefore, it acts as an alternative signal for protein degradation, indicating a role in generating the peptide pool for MHC-I presentation. In this study, we aimed to elucidate the role of FAT10 in MHC class I presentation.
Methods: Using different human and mouse cell lines deficient for FAT10, the effect of FAT10 on MHC-I surface expression and recovery was studied. For the evaluation of antigen presentation of viral and endogenous epitopes, T cell hybridoma assays and flow cytometry analysis were used.
Results: In our study, using model antigens and FAT10-deficient cells, we found that the absence of FAT10 does not affect the abundance of MHC-I molecules or the generation of endogenous and virus-derived MHC-I epitopes. Furthermore, we demonstrated that the cytotoxic T cell response to different viruses remains unchanged in FAT10-deficient mice compared to wild-type mice.
Discussion: In summary, our findings indicate that the lack of FAT10 does not impact antigen presentation or the cytotoxic T-cell response across a number of different MHC-I-restricted peptides. Hence, we conclude that the contribution of FAT10 to MHC-I antigen presentation has previously been overestimated.</dcterms:abstract>
<bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/74477"/>
<dcterms:title>The ubiquitin-like modifier FAT10 is not essential for MHC-I antigen presentation</dcterms:title>
<dc:contributor>Aichem, Annette</dc:contributor>
<dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
<dcterms:issued>2025</dcterms:issued>
<dc:creator>Ochs, Sarah</dc:creator>
<dc:contributor>Pach, Natalie</dc:contributor>
<dcterms:rights rdf:resource="https://rightsstatements.org/page/InC/1.0/"/>
<dc:creator>Pach, Natalie</dc:creator>
<dc:contributor>Basler, Michael</dc:contributor>
<dc:contributor>Cao, Jinjing</dc:contributor>
<dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/74477/1/Pach_2-1707wzlwlltme1.pdf"/>
<void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
<dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2025-09-05T10:32:04Z</dc:date>
<dc:creator>Aichem, Annette</dc:creator>
<dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
<dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/74477/1/Pach_2-1707wzlwlltme1.pdf"/>
<dc:creator>Ottlinger, Julia</dc:creator>
<dc:creator>Basler, Michael</dc:creator>
</rdf:Description>
</rdf:RDF> | |
| kops.description.openAccess | openaccessgold | |
| kops.flag.isPeerReviewed | true | |
| kops.flag.knbibliography | true | |
| kops.identifier.nbn | urn:nbn:de:bsz:352-2-1707wzlwlltme1 | |
| kops.sourcefield | Frontiers in Immunology. Frontiers. 2025, <b>16</b>, 1636951. eISSN 1664-3224. Verfügbar unter: doi: 10.3389/fimmu.2025.1636951 | deu |
| kops.sourcefield.plain | Frontiers in Immunology. Frontiers. 2025, 16, 1636951. eISSN 1664-3224. Verfügbar unter: doi: 10.3389/fimmu.2025.1636951 | deu |
| kops.sourcefield.plain | Frontiers in Immunology. Frontiers. 2025, 16, 1636951. eISSN 1664-3224. Available under: doi: 10.3389/fimmu.2025.1636951 | eng |
| relation.isAuthorOfPublication | 9afe818e-2c47-4673-a5d1-0297ae7c8562 | |
| relation.isAuthorOfPublication | 9c11da52-b637-4e3a-9e54-6cbb7e8187e4 | |
| relation.isAuthorOfPublication | d9f02c51-17ad-449e-b474-6ebd5cab64da | |
| relation.isAuthorOfPublication | 330796af-42ba-48a0-90d1-d3b196277661 | |
| relation.isAuthorOfPublication | fbcff69e-b4e8-4740-9123-cc2abad5b2af | |
| relation.isAuthorOfPublication.latestForDiscovery | fbcff69e-b4e8-4740-9123-cc2abad5b2af | |
| source.bibliographicInfo.articleNumber | 1636951 | |
| source.bibliographicInfo.volume | 16 | |
| source.identifier.eissn | 1664-3224 | |
| source.periodicalTitle | Frontiers in Immunology | |
| source.publisher | Frontiers |
Dateien
Originalbündel
1 - 1 von 1
Vorschaubild nicht verfügbar
- Name:
- Pach_2-1707wzlwlltme1.pdf
- Größe:
- 2.11 MB
- Format:
- Adobe Portable Document Format
Lizenzbündel
1 - 1 von 1
Vorschaubild nicht verfügbar
- Name:
- license.txt
- Größe:
- 3.96 KB
- Format:
- Item-specific license agreed upon to submission
- Beschreibung:

